I. Introduction
Stem cells are immature, undifferentiated cells that can divide and multiply for an extended period of time, differentiating into specific types of cells and tissues. Stem cells that reside in dental pulp, called dental pulp stem cells (DPSCs) are considered as a population of MSCs. Autogenous stem cells are derived from the patient being treated, while allogenous stem cells are derived from other individuals. Stem cells available commercially are mainly allogenous and will not produce an immune response. whereas, autogenous reduce the risk of rejection 1 . The process by which stem cells are derived from one type of tissue and differentiate into other types of tissue is referred to as plasticity or transdifferentiation 2 . Stem cells can be divided into two categories -embryonic and adult. Embryonic stem cells are totipotent cells derived from the early mammalian embryo at the blastocyst stage able to differentiate into any cell type, as well as being propagated indefinitely in an undifferentiated state 3 . However, embryonic cells loose these properties as differentiation ensues and growth-promoting signals decline. Adult stem cells are not totipotent, and they can be further classified depending on their origin and differentiation potential 3, 4, 5, 6, 7, 8, 9 .
There are different population of stems cells like hematopoietic stem cells, bone marrow stromal cells and postnatal stem cells. Dental pulp stem cells represent a postnatal stem cells, capable of extensive proliferation and multipotential differentiation. The general properties of stem cells are unspecialized; continuous self-renewal; and can give rise to specialized cell types. Dental pulp stem cells are attractive for their potential to differentiate into several cell types including odontoblasts, neural progenitors, chondrocytes, endothelocytes, adipocytes, smooth muscle cells and osteoblasts. (Sloan & Waddington, 2009) 10 .
II. Sources of Dental pulp stem cells
The first type of dental stem cell was isolated from the human pulp tissue and termed dental pulp stem cells (DPSCs) by Gronthos et al., 2000 based on their clonogenic abilities and rapid proliferative rates. In human postnatal dental tissue, five different sources of mesenchymal stem cells (MSCs) have been already identified: dental pulp, periodontal ligament, exfoliated deciduous teeth, dental follicle (DF), and root apical papilla. These dental stem cells are derived from the neural crest, and thus have a different origin from bone marrow-derived MSCs, which are derived from mesoderm. Among them, all except SHED are from permanent teeth 11 .
Deciduous verus permanent dental pulp stem cells
The dental pulp stem cells from the permanent third molar were first isolated by Gronthos et al 12 who have described the cells as colonogenic cells capable of producing osteoblastic and chondrocytic cells in vitro and odontoblastic cells in vivo. Investigations have indicated the broad differentiation capacity of the pulp derived cells including their ability in giving rise to neural and endothelial cell lineages as well 13, 14, 15 . These
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III. Clinical applications
Dental pulp is most feasible and rich source of mesenchymal stem cells: Dental Pulp Stem cells (DPSc) to be used in regenerative therapy. The physiologically intact dental pulp stem cells could be successfully differentiated to advanced derivatives of all three primary germlayers (odontoblast, osteoblast, chondrocyte, myocyte, neurocyte, adipocyte, corneal epithelial cell, melanoma cell,induced pluripotent stem cells iPSC) 19. Stem cell-based therapies are being investigated for the treatment of many conditions, including neurodegenerative conditions such as Parkinson's Disease and Multiple Sclerosis, liver disease, diabetes, cardiovascular disease, autoimmune diseases, musculoskeletal disorders and for nerve regeneration following brain or spinal cord injury. Currently, patients are being treated using stem cells for bone fractures, cancer (bone marrow transplants) and spinal fusion surgery. New stem cell therapies are continually under review, and some have already been approved by the U.S. Food and Drug Administration 20 . The comprehensive list of diseases and conditions currently being treated using stem cells include Stem Cell Disorders, Acute and chronic Leukemias, Myeloproliferative Disorders, Myelodysplastic Syndromes, Lymphoproliferative Disorders, Inherited Erythrocyte Abnormalities, Liposomal Storage Diseases, Histiocytic Disorders, Phagocyte Disorders, Congenital Immune System Disorders, Inherited Platelet Abnormalities, Plasma Cell Disorders and malignancies 21, 22, 23 . The applications related to oral health care have included regeneration of an immature tooth with extensive coronal and pulp damage, regeneration of resorbed root, cervical, or apical dentin, periodontal regeneration, whole-tooth regeneration, repair and replacement of bone in craniofacial defects(eg, repair of cleft lip/palate) can facilitate restoring the physiologic structural integrity. The successful regeneration of periodontal tissue, alveolar bone, cementum, and periodontal ligament has been achieved using autologous periodontal ligament mesenchymal stem cells (PDL-MSCs) 24 . The regeneration of orodental tissues is dependent on four basic components. The appropriate signals, cells, blood supply, and scaffold that are needed to target the tissue at the site of defect. All these components are essential for reconstruction and healing of lost tissues. The cells provide the machinery for new tissue growth and differentiation, whereas the growth factors modulate the cellular activity and stimulate the cells to differentiate as well as produce tissue matrix. The new vascular tissues provide the nutritional base for tissue growth and the scaffolds guide and create a template structure in three-dimensions to facilitate the tissue regeneration process 25 .
IV. Stem Cell Handling and Cryopreservation
Stem cells are released from small amounts of tissue, in the case of dental stem cells from dental pulp. The tissue is placed in an enzyme solution that releases the stem cells, which are then cultured to multiply. This can be accomplished using serum-free medium, removing the need for use of animal serum. Differentiation then occurs and the cells are transplanted -either alone or with a scaffold or other biomaterials, depending on the application.
Extracted permanent and deciduous (including exfoliating) teeth can be preserved for future use with cryopreservation. The cells are rapidly cooled to subzero temperatures as low as −196°, stopping any cellular or biochemical activity. Rapid freezing is necessary to prevent ice from forming around or inside the cells and to prevent dehydration, as these would cause cell damage and death. Research has demonstrated that stem cells derived from the dental pulp of extracted third molars retain the ability to differentiate into multiple cell types following thawing after cryopreservation using liquid nitrogen. Stem cells derived from the periodontal ligament are viable following cryopreservation. After two years of cryopreservation, stem cells have been able to differentiate and to proliferate, and it has been concluded that DSCs can undergo long-term cryopreservation 26, 27, 28 .
V. Conclusion
Banking teeth and dental stem cells offers patients a viable alternative to using more invasive or ethically problematic sources of stem cells, and harvesting can be done during routine procedures in adults and from the deciduous teeth of children. The possibility of using stem cells, biological molecules and tissue engineering in clinical dentistry, opens completely new approaches to restore functionally and an aesthetically suitable tooth arch. Now, dental professionals have the opportunity to make their patients aware of these new sources of stem cells that can be conveniently recovered and remotely stored for future use as new therapies are developed for a range of diseases and injuries.
